about
Applying a hypoxia-incorporating TCP model to experimental data on rat sarcoma.Dose-volume-related dysphagia after constrictor muscles definition in head and neck cancer intensity-modulated radiation treatment.Volumetric-modulated arc stereotactic body radiotherapy for prostate cancer: dosimetric impact of an increased near-maximum target dose and of a rectal spacer.SBRT for prostate cancer: Challenges and features from a physicist prospective.Radiation dose intensification in pre-operative chemo-radiotherapy for locally advanced rectal cancer.Moderate Hypofractionated Postprostatectomy Volumetric Modulated Arc Therapy With Daily Image Guidance (VMAT-IGRT): A Mono-institutional Report on Feasibility and Acute Toxicity.Synchronous bilateral breast cancer irradiation: clinical and dosimetrical issues using volumetric modulated arc therapy and simultaneous integrated boost.Simultaneous integrated bilateral breast and nodal irradiation with volumetric arc therapy: case report and literature review.Optimal dose and fraction number in SBRT of lung tumours: A radiobiological analysis.Cachexia induces head and neck changes in locally advanced oropharyngeal carcinoma during definitive cisplatin and image-guided volumetric-modulated arc radiation therapy.Intensity modulated radiation therapy with simultaneous integrated boost in early breast cancer irradiation. Report of feasibility and preliminary toxicity.Weekly Cisplatin and Volumetric-Modulated Arc Therapy With Simultaneous Integrated Boost for Radical Treatment of Advanced Cervical Cancer in Elderly Patients: Feasibility and Clinical Preliminary ResultsCone-beam computed tomography in lung stereotactic ablative radiation therapy: predictive parameters of early response.Hypofractionation in non-small cell lung cancer (NSCLC): suggestions from modelling both acute and chronic hypoxia.Hippocampal dose during Linac-based stereotactic radiotherapy for brain metastases: An observational study.Computed 88% TCP dose for SBRT of NSCLC from tumour hypoxia modelling.Impact of 18F-Choline PET/CT in the Decision-Making Strategy of Treatment Volumes in Definitive Prostate Cancer Volumetric Modulated Radiation Therapy.Technical Note: Multicenter study of TrueBeam FFF beams with a new stereotactic diode: Can a common small field signal ratio curve be defined?Stereotactic ablative radiation therapy for brain metastases with volumetric modulated arc therapy and flattening filter free delivery: feasibility and early clinical results.The impact of hypofractionation on simultaneous dose-boosting to hypoxic tumor subvolumes.Analytical investigation of the possibility of parameter invariant TCP-based radiation therapy plan ranking.Severe hypofractionation: non-homogeneous tumour dose delivery can counteract tumour hypoxia.Linac-based VMAT radiosurgery for multiple brain lesions: comparison between a conventional multi-isocenter approach and a new dedicated mono-isocenter technique.Stereotactic Ablative Radiation Therapy for Lung Oligometastases: Predictive Parameters of Early Response by 18FDG-PET/CT.Lung stereotactic ablative body radiotherapy: A large scale multi-institutional planning comparison for interpreting results of multi-institutional studies.Nasal cavity reirradiation: a challenging case for comparison between proton therapy and volumetric modulated arc therapy.Technical Note: Correction for intra-chamber dose gradients in reference dosimetry of flattening-filter-free MV photon beams.On differences in radiosensitivity estimation: TCP experiments versus survival curves. A theoretical study.Whole brain radiotherapy with hippocampal avoidance and simultaneous integrated boost for brain metastases: a dosimetric volumetric-modulated arc therapy studyThe impact of prostate gland dimension in genitourinary toxicity after definitive prostate cancer treatment with moderate hypofractionation and volumetric modulated arc radiation therapyPredictors of mucositis in oropharyngeal and oral cavity cancer in patients treated with volumetric modulated radiation treatment: A dose-volume analysisLow-dose bath with volumetric modulated arc therapy in breast cancer: "Much ado about nothing?"Three-dimensional conformal versus intensity modulated radiotherapy in breast cancer treatment: is necessary a medical reversal?Applying radiobiological plan ranking methodology to VMAT prostate SBRTLinac-based radiosurgery for multiple brain metastases: Comparison between two mono-isocenter techniques with multiple non-coplanar arcsModelling the effect of spread in radiosensitivity parameters and repopulation rate on the probability of tumour control
P50
Q34136429-3D986C97-31E5-4A0C-95E5-3D5FB0321783Q34568221-7357A6F2-AB50-45A2-B453-A755E15BE0ABQ36535570-40532F7C-AACB-472D-8ECC-BBCC60958C4FQ38803177-05AC602E-3986-4E52-AE89-C1780750C7A9Q38857880-4C008E00-C221-4DFD-9B65-11C8732D4E43Q38942326-084399B8-B416-4DBA-86E7-81307F9F8930Q38948817-6C5A6E49-EDE0-4D28-9E42-BA29D80216F6Q38975115-3E4091E3-9840-4313-9BA7-0A675D39CD13Q38994749-6F0B58B7-AF4C-49CD-8A66-38F18BE857F3Q39856469-7A860DD2-D463-434B-BE7B-3531B6B049C6Q40701137-AA4C7A5F-04F2-43D7-B358-48135D8669EFQ42042375-93E907DC-3848-478A-8931-C5773AA5C723Q42116312-F7F8651A-8FE6-4B04-9657-D4350231132CQ47889165-D04559AC-CDB3-421E-9226-B83BB7B3AF21Q48095675-D0A7DF3D-4AA2-4BE2-9F2B-B6A8861CC957Q48949702-6238EDF8-0ECF-4BB3-AF87-2B501B6A8966Q49039176-308A0BA3-6023-44FA-A327-1BB026898246Q50560082-D3FDF1A5-1C5F-4684-A1CC-03B8E09376D9Q50697335-60618D2F-7C49-4F2B-965A-F2E1C85E1C48Q51628396-539B235B-81EA-4E97-AB3B-BF23DA0B17EFQ51647357-0EF468BF-F24A-48CE-AF3D-8965F84856B4Q51694927-1EE2A17E-149B-44DB-BD1D-CB23FA01750BQ51744229-521548AD-FE88-4364-917C-0B864A4155DFQ52953787-C2DDC335-904D-4584-A568-DDED5F011F58Q52983746-4B94ABBC-30F2-4AE7-A3A5-1E838FE3DF89Q52999792-E69A0FC3-4327-4548-AF60-36073DACBB44Q53045573-B88D41CF-2775-4193-8ABD-40A979400FACQ53406109-860A8F79-3AF2-48D1-950D-EA3DAD779535Q85689114-7CFE0A17-D2C4-4FDC-B693-CF1EAA28B0D9Q85849351-E3E278E8-C07D-4675-A4FB-E97C8138A5CDQ87204284-8F54EBCD-31BC-4425-9A6E-179EF31BCE5AQ87741912-8A296268-6A86-4384-9789-B7F17D871A3DQ88621066-899F7166-67C0-4851-AB84-40D76B6CFC58Q89210355-859F80C9-8478-4BF6-B352-6A7B42F4DB2EQ92071510-42A109C6-A60A-484C-B50D-311D026F1A64Q92913806-8269B30C-BA38-4183-B1DB-A3AEF3E4F695
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Ruggero Ruggieri
@ast
Ruggero Ruggieri
@en
Ruggero Ruggieri
@es
Ruggero Ruggieri
@nl
Ruggero Ruggieri
@sl
type
label
Ruggero Ruggieri
@ast
Ruggero Ruggieri
@en
Ruggero Ruggieri
@es
Ruggero Ruggieri
@nl
Ruggero Ruggieri
@sl
prefLabel
Ruggero Ruggieri
@ast
Ruggero Ruggieri
@en
Ruggero Ruggieri
@es
Ruggero Ruggieri
@nl
Ruggero Ruggieri
@sl
P106
P1153
7003909915
P31
P496
0000-0002-2044-8035